The death-promoting molecule tumour necrosis factor-related apoptosis inducing ligand (TRAIL) is not required for the development of peripheral lymphopenia or granuloma necrosis during infection with virulent Mycobacterium avium

Clinical and Experimental Immunology

Volumn 164, Issue 3, 2011, Pages 407-416

  Borges, M ^a,b   Rosa, G T ^a   Appelberg, R ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

Apoptosis; Lymphopenia; Mycobacteria; Pathology

Indexed keywords

CASPASE 8; GAMMA INTERFERON; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA FRAGMENTATION; ENZYME ACTIVITY; GRANULOMA; LYMPHOCYTOPENIA; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM AVIUM; NONHUMAN; NUCLEOSOME; PRIORITY JOURNAL; PROTEIN FUNCTION; SPLEEN CELL; TUMOR NECROSIS; UPREGULATION;

ANIMALS; APOPTOSIS; CASPASE 8; CD4-POSITIVE T-LYMPHOCYTES; DISEASE SUSCEPTIBILITY; DNA FRAGMENTATION; GRANULOMA; INTERFERON-GAMMA; LYMPHOPENIA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYCOBACTERIUM AVIUM; NECROSIS; SPLEEN; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUBERCULOSIS; UP-REGULATION;

EID: 79955485316     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2011.04385.x     Document Type: Article

References (40)

1. Appelberg R. Pathogenesis of Mycobacterium avium infection: typical responses to an atypical mycobacterium? Immunol Res 2006; 35:179-90.
2. Das G, Vohra H, Saha B, Agrewala JN, Mishra GC. Apoptosis of Th1-like cells in experimental tuberculosis (TB). Clin Exp Immunol 1999; 115:324-8.
3. Flórido M, Goncalves AS, Silva RA, Ehlers S, Cooper AM, Appelberg R. Resistance of virulent Mycobacterium avium to gamma interferon-mediated antimicrobial activity suggests additional signals for induction of mycobacteriostasis. Infect Immun 1999; 67:3610-8.
4. Gilbertson B, Zhong J, Cheers C. Anergy, IFN-gamma production, and apoptosis in terminal infection of mice with Mycobacterium avium. J Immunol 1999; 163:2073-80.
5. Hirsch CS, Toossi Z, Johnson JL etal. Augmentation of apoptosis and interferon-gamma production at sites of active Mycobacterium tuberculosis infection in human tuberculosis. J Infect Dis 2001; 183:779-88.
6. Zhong J, Gilbertson B, Cheers C. Apoptosis of CD4+ and CD8+ T cells during experimental infection with Mycobacterium avium is controlled by Fas/FasL and Bcl-2-sensitive pathways, respectively. Immunol Cell Biol 2003; 81:480-6.
7. Grossman Z, Meier-Schellersheim M, Sousa AE, Victorino RM, Paul WE. CD4+ T-cell depletion in HIV infection: are we closer to understanding the cause? Nat Med 2002; 8:319-23.
8. Flórido M, Pearl JE, Solache A etal. Gamma interferon-induced T-cell loss in virulent Mycobacterium avium infection. Infect Immun 2005; 73:3577-86.
9. Flórido M, Appelberg R. Characterization of the deregulated immune activation occurring at late stages of mycobacterial infection in TNF-deficient mice. J Immunol 2007; 179:7702-8.
10. Wiley SR, Schooley K, Smolak PJ etal. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995; 3:673-82.
11. Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A, Ashkenazi A. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 1996; 271:12687-1290.
12. Walczak H, Miller RE, Ariail K etal. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 1999; 5:157-63.
13. Schaefer U, Voloshanenko O, Willen D, Walczak H. TRAIL: a multifunctional cytokine. Front Biosci 2007; 12:3813-24.
14. Falschlehner C, Schaefer U, Walczak H. Following TRAIL's path in the immune system. Immunology 2009; 127:145-54.
15. Sedger LM, Shows DM, Blanton RA etal. IFN-gamma mediates a novel antiviral activity through dynamic modulation of TRAIL and TRAIL receptor expression. J Immunol 1999; 163:920-6.
16. Shin EC, Ahn JM, Kim CH etal. IFN-gamma induces cell death in human hepatoma cells through a TRAIL/death receptor-mediated apoptotic pathway. Int J Cancer 2001; 93:262-8.
17. Park SY, Seol JW, Lee YJ etal. IFN-gamma enhances TRAIL-induced apoptosis through IRF-1. Eur J Biochem 2004; 271:4222-8.
18. Secchiero P, Mirandola P, Zella D etal. Human herpesvirus 7 induces the functional up-regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) coupled to TRAIL-R1 down-modulation in CD4(+) T cells. Blood 2001; 98:2474-81.
19. Roe MF, Bloxham DM, White DK, Ross-Russell RI, Tasker RT, O'Donnell DR. Lymphocyte apoptosis in acute respiratory syncytial virus bronchiolitis. Clin Exp Immunol 2004; 137:139-45.
20. Badley AD, Pilon AA, Landay A, Lynch DH. Mechanisms of HIV-associated lymphocyte apoptosis. Blood 2000; 96:2951-64.
21. Miura Y, Koyanagi Y. Death ligand-mediated apoptosis in HIV infection. Rev Med Virol 2005; 15:169-78.
22. Herbeuval JP, Grivel JC, Boasso A etal. CD4+ T-cell death induced by infectious and noninfectious HIV-1: role of type 1 interferon-dependent, TRAIL/DR5-mediated apoptosis. Blood 2005; 106:3524-31.
23. Zheng SJ, Jiang J, Shen H, Chen YH. Reduced apoptosis and ameliorated listeriosis in TRAIL-null mice. J Immunol 2004; 173:5652-8.
24. Vidalain PO, Azocar O, Lamouille B, Astier A, Rabourdin-Combe C, Servet-Delprat C. Measles virus induces functional TRAIL production by human dendritic cells. J Virol 2000; 74:556-9.
25. Yang Y, Tikhonov I, Ruckwardt TJ etal. Monocytes treated with human immunodeficiency virus Tat kill uninfected CD4+ cells by a tumor necrosis factor-related apoptosis-inducing ligand-mediated mechanism. Infect Immun 2003; 77:6700-8.
26. Flórido M, Cooper AM, Appelberg R. Immunological basis of the development of necrotic lesions following Mycobacterium avium infection. Immunology 2002; 106:590-601.
27. Flórido M, Appelberg R. Granuloma necrosis during Mycobacterium avium infection does not require tumor necrosis factor. Infect Immun 2004; 72:6139-41.
28. Flórido M, Appelberg R. Genetic control of immune-mediated necrosis of Mycobacterium avium granulomas. Immunology 2006; 118:122-30.
29. Mahalingam D, Szegezdi E, Keane M, Jong S, Samali A. TRAIL receptor signalling and modulation: are we on the right TRAIL? Cancer Treat Rev 2009; 35:280-8.
30. Cui M, Wang L, Liang X etal. Blocking TRAIL-DR5 signaling with soluble DR5 reduces delayed neuronal damage after transient global cerebral ischemia. Neurobiol Dis 2010; 39:138-47.
31. Razmara M, Hilliard B, Ziarani AK etal. Fn14-TRAIL, a chimeric intercellular signal exchanger, attenuates experimental autoimmune encephalomyelitis. Am J Pathol 2009; 174:460-74.
32. Harris J, Keane J. How tumour necrosis factor blockers interfere with tuberculosis immunity. Clin Exp Immunol 2010; 161:1-9.
33. Sedger LM, Glaccum MB, Schuh JC etal. Characterization of the in vivo function of TNF-alpha-related apoptosis-inducing ligand, TRAIL/Apo2L, using TRAIL/Apo2L gene-deficient mice. Eur J Immunol 2002; 32:2246-54.
34. Flórido M, Gonçalves AS, Silva RA, Ehlers S, Cooper AM, Appelberg R. Resistance of virulent Mycobacterium avium to gamma interferon-mediated antimicrobial activity suggests additional signals for induction of mycobacteriostasis. Infect Immun 1999; 67:3610-8.
35. Pais TF, Cunha JF, Appelberg R. Antigen specificity of T-cell response to Mycobacterium avium infection in mice. Infect Immun 2000; 68:4805-10.
36. Diehl GE, Ye HH, Hsieh K etal. TRAIL-R as a negative regulator of innate immune cell responses. Immunity 2004; 21:877-89.
37. Sato K, Hida S, Takayanagi H etal. Antiviral response by natural killer cells through TRAIL gene induction by IFNα/β. Eur J Immunol 2001; 31:3138-46.
38. Chou AH, Tsai HF, Lin LL, Hsieh SL, Hsu PI, Hsu PN. Enhanced proliferation and increased IFN-γ production in T cells by signal transduced through TNF-related apoptosis-inducing ligand. J Immunol 2001; 167:1347-52.
39. Flórido M, Borges M, Yagita H, Appelberg R. Contribution of CD30/CD153 but not of CD27/CD70, CD134/OX40L, or CD137/4-1BBL to the optimal induction of protective immunity to Mycobacterium avium. J Leukoc Biol 2004; 76:1039-46.
40. Flórido M, Gonçalves AS, Gomes MS, Appelberg R. CD40 is required for the optimal induction of protective immunity to Mycobacterium avium. Immunology 2004; 111:323-7.